Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by (999)

Items 401–500 of 999

1. START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection
   Mark Jacob Siedner · 2016 · Open Forum Infectious Diseases
2. Epidemiology of coronary heart disease in patients with human immunodeficiency virus.
   Virginia A. Triant · 2014 · PubMed
3. Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals
   Margalida Rotger, Cornelia Bayard, Patrick Taffé, Raquel Martínez, Matthias L. Cavassini, Enos Bernasconi, Manuel Battegay, Bernard J. Hirschel, Hansjakob Furrer, Andrea Witteck et al. · 2009 · Circulation Cardiovascular Genetics
4. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
   Francisco Blanco, Jesús San Román, Eugenia Vispo, Mariola López, Antonio Salto, Vanesa Abad, Vincent Soriano · 2010 · PubMed
5. Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons*
   Nancy F. Crum‐Cianflone, David J Krause, Dylan E. Wessman, Silvia Medina, James E. Stepenosky, C Brandt, Garry W. Boswell · 2011 · HIV Medicine
6. Coronary atherosclerotic lesions in human immunodeficiency virus–infected patients: a histopathologic study
   Robert G. Micheletti, Gregory A. Fishbein, Michael C. Fishbein, Elyse J. Singer, Robert E. Weiss, Robin A. Jeffries, Judith S. Currier · 2008 · Cardiovascular Pathology
7. Should We Treat Acute HIV Infection?
   Meagan P. O’Brien, Martin H. Markowitz · 2012 · Current HIV/AIDS Reports
8. Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study
   Samir Kumar Gupta, Changyu Shen, Sharon M. Moe, Lisa M. Kamendulis, Mitchell Goldman, Michael P. Dubé · 2012 · PLoS ONE
9. Increased Coronary Vessel Wall Thickness in HIV-Infected Young Adults
   Khaled Z. Abd‐Elmoniem, Aylin B. Unsal, Sarah Eshera, Jatin R. Matta, Nancy Muldoon, Dorothea McAreavey, Julia Purdy, Rohan Hazra, Colleen M. Hadigan, Ahmed M. Gharib · 2014 · Clinical Infectious Diseases
10. Cardiorespiratory fitness levels and moderators in people with HIV: A systematic review and meta-analysis
    Davy Vancampfort, James Mugisha, Simon Rosenbaum, Joseph Firth, Marc De Hert, Michel Probst, Brendon Stubbs · 2016 · Preventive Medicine
11. HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study
    The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group · 2010 · Antiviral Therapy
12. Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis
    Michael I. Brener, Kerunne S. Ketlogetswe, Matthew Jay Budoff, Lisa P. Jacobson, Xiuhong Li, Panteha Rezaeian, Aryabod Razipour, Frank Joseph Palella, Lawrence Kingsley, Mallory D. Witt et al. · 2014 · AIDS
13. Asymptomatic myocardial ischaemia in HIV-infected adults
    Andrew D Carr, Birgit Grund, Jacqueline Neuhaus, Wafaa M. El-Sadr, Gregory A. Grandits, Cynthia L. Gibert, Ronald J. Prineas · 2008 · AIDS
14. Cardiovascular risk factors and HIV disease.
    Francesco Fedele, Noemi Bruno, Massimo Mancone · 2011 · PubMed
15. Understanding mechanisms to promote successful aging in persons living with HIV
    Gerome V. Escota, Jane A. O’Halloran, William G. Powderly, Rachel M. Presti · 2017 · International Journal of Infectious Diseases
16. Ageing with HIV
    Pádraig McGettrick, Elena Álvarez Barco, Patrick W. G. Mallon · 2018 · Healthcare
17. Coronary Artery Disease Manifestations in HIV: What, How, and Why
    Arjun Sinha, Matthew J. Feinstein · 2018 · Canadian Journal of Cardiology
18. HIV/AIDS Patients with HIV Vasculopathy and VZV Vasculitis
    José Gutierrez, Gustavo A. Ortiz · 2011 · Clinical Neuroradiology
19. Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens
    Paolo Maggi, Chiara Bellacosa, Valentina Carito, Francesco Perilli, Antonio Lillo, Anna Rita Volpe, Giovanna Trillo, Domenico Angiletta, Guido Regina, Gioacchino Angarano · 2011 · Journal of Antimicrobial Chemotherapy
20. Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012
    Eugenia Quirós-Roldán, Elena Raffetti, Emanuele Focà, Nigritella Brianese, Alice Ferraresi, Giuseppe Paraninfo, Maria Chiara Pezzoli, Andrea Bonito, Michele Magoni, Carmelo Scarcella et al. · 2016 · AIDS Care
21. Inflammation and Complications of HIV Disease
    Michael P. Dubé, Fred R. Sattler · 2010 · The Journal of Infectious Diseases
22. Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients
    Paolo Raggi, Stefano Zona, Riccardo Scaglioni, Chiara Stentarelli, Guido Ligabue, Giulia Besutti, Marianna Menozzi, Antonella Santoro, Andrea Malagoli, Antonio Bellasi et al. · 2015 · Journal of cardiovascular computed tomography
23. Framingham Risk Score and Early Markers of Atherosclerosis in a Cohort of Adults Infected with HIV
    Emilia Liana Falcone, Alexandra Mangili, Sally C. Skinner, Ahsan Alam, Joseph F. Polak, CHRISTINE A. WANKE · 2010 · Antiviral Therapy
24. Smoking and HIV: time for a change?
    Nicola Petrosillo, Stefania Cicalini · 2013 · BMC Medicine
25. Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy
    Y. Hacioglu, Mohit Dayal Gupta, Tae-Young Choi, Richard T. George, Christopher R. Deible, Lisa P. Jacobson, Mallory D. Witt, Frank Joseph Palella, Wendy S. Post, Matthew Jay Budoff · 2013 · The Anatolian Journal of Cardiology
26. Characteristics of hypertension among people living with HIV in Ghana: Impact of new hypertension guideline
    Fred Stephen Sarfo, Michelle G. Nichols, Arti Singh, Yasmine Oladele Hardy, Betty Norman, Gideon Mensah, Ralle Tagge, Carolyn M. Jenkins, Bruce I Ovbiagele · 2019 · Journal of Clinical Hypertension
27. Highly Sensitive C-Reactive Protein, Body Mass Index, and Serum Lipids in HIV-Infected Persons Receiving Antiretroviral Therapy: A Longitudinal Study
    Michael S Boger, Ayumi Shintani, Leigh Anne Redhage, Valerie J. Mitchell, David W. Haas, Jason D. Morrow, Todd Hulgan · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
28. Dyslipidemia in HIV-infected individuals
    Eduardo Sprinz, Rosmeri Kuhmmer Lazzaretti, Regina Kuhmmer, Jorge Pinto Ribeiro · 2010 · The Brazilian Journal of Infectious Diseases
29. Cardiovascular Effects of Noncardiovascular Drugs
    Satish R. Raj, C. Michael Stein, Pablo J. Saavedra, Dan M. Roden · 2009 · Circulation
30. The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy
    José Antonio Pérez-Molina, Peré Domingo, Estebán Martínez, Santiago Moreno · 2008 · Journal of Antimicrobial Chemotherapy
31. Management of dyslipidemia in HIV-infected patients
    Mary C. Sugden, Mark J. Holness · 2011 · Clinical Lipidology
32. HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
    Jeffrey C. Laurence, Sonia Elhadad, Jasimuddin Ahamed · 2018 · Open Heart
33. Diabetes Mellitus, Cardiovascular Risk, and HIV Disease
    Steven Kyle Grinspoon · 2009 · Circulation
34. Cardiovascular Risk Estimation Is Suboptimal in People With HIV
    Virginia A. Triant, Asya Lyass, Leo Bartemeier Hurley, Leila H. Borowsky, Rachel Q. Ehrbar, Wei Wu He, David Ting-Yuan Cheng, Janet Lo, Daniel Benjamin Klein, James B. Meigs et al. · 2024 · Journal of the American Heart Association
35. Screening for chronic comorbid diseases in people with HIV : the need for a strategic approach
    B Peters, Frank A. Post, Anthony S. Wierzbicki, Andrew N. Phillips, Lorne Power, Samarendra Das, Margaret A. Johnson, Graeme J Moyle, L Hughes, Ed Wilkins et al. · 2012 · HIV Medicine
36. Correlates of Hypertension in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy
    Katherine Krauskopf, Mark L. Van Natta, Ronald P. Danis, Sapna Gangaputra, Lori Ackatz, Adrienne Addessi, Alex D. Federman, Andrea D. Branch, Curtis L. Meinert, Douglas A. Jabs · 2013 · Journal of the International Association of Providers of AIDS Care (JIAPAC)
37. Effect of Specific ART Drugs on Lipid Changes and the Need for Lipid Management in Children With HIV
    Margaret P. Rhoads, Julie Lanigan, Colette J Smith, E. G. Hermione Lyall · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
38. Decreased ovarian reserve in HIV-infected women
    Piétro Santulli, Diane de Villardi, Vanessa Gayet, Marie-Christine Lafay-Pillet, Louis Marcellin, Valerie Blanchet, Julia Gonnot, Emmanuel Dulioust, Odile Launay, Charles Chapron · 2016 · AIDS
39. Prevalence and health effects of communicable and non‐communicable disease comorbidity in rural KwaZulu‐Natal, South Africa
    Monica Sharman, Max Oscar Bachmann · 2019 · Tropical Medicine & International Health
40. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms
    Sergio Serrano Villar, Vicente Estrada, Dulcenombre Gómez‐Garré, Mario Ávila, Manuel Enrique Fuentes, Román Jesús San, Vincent Soriano, Clara Sánchez-Parra, Talía Sainz, Arturo Fernández‐Cruz · 2012 · European Journal of Preventive Cardiology
41. Toxicogenetics of Antiretroviral Therapy: Genetic Factors that Contribute to Metabolic Complications
    PHILIP E. TARR, Amalio Telenti · 2007 · Antiviral Therapy
42. Challenges in Using Observational Studies to Evaluate Adverse Effects of Treatment
    Michael D. Hughes, Paige L. Williams · 2007 · New England Journal of Medicine
43. Human Immunodeficiency Virus Infection and Diverse Physical Health Outcomes: An Umbrella Review of Meta-analyses of Observational Studies
    Igor Grabovac, Nicola Veronese, Siniša Štefanac, Sandra Haider, Sarah E. Jackson, Ai Koyanagi, Michael Meilinger, Brendon Stubbs, Joseph Firth, Pınar Soysal et al. · 2019 · Clinical Infectious Diseases
44. Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)
    Daniel Podzamczer, Jaime Federico Andrade-Villanueva, Bonaventura Clotet, Stephen R. Taylor, Jürgen Kurt Rockstroh, Peter Reiss, Peré Domingo, Holger Gellermann, Lothar de Rossi, Victoria E. Cairns et al. · 2011 · HIV Medicine
45. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection
    Caroline Foster, Sarah J. Fidler · 2010 · Expert Review of Anti-infective Therapy
46. Lipoprotein Disorders and Cardiovascular Disease
    Jacques J. Genest, Peter Libby · 2012 · Elsevier eBooks
47. Trends in mortality among ART‐treated HIV‐infected adults in the Asia‐Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia‐Pacific
    In Young Jung, Dhanushi Rupasinghe, Ian John Woolley, Catherine C O'Connor, Michelle Giles, Iskandar Azwa, Jun Yong Choi, IeDEA Asia‐Pacific · 2019 · Journal of the International AIDS Society
48. HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells
    Martine Auclair, Anne-Claire Guénantin, Soraya Fellahi, Marie Garcia, Jacqueline Capeau · 2020 · PLoS ONE
49. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes
    Emma Kate Zadow, Daniel William Taylor Wundersitz, Diane L. Hughes, Murray John Adams, Michael Kingsley, Hilary Anne Blacklock, Sam Shi Xuan Wu, Amanda Clare Benson, Frédéric Dutheil, Brett Ashley Gordon · 2020 · Seminars in Thrombosis and Hemostasis
50. HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation
    Thiago B Bruder-Nascimento, Taylor C. Kress, Simone Kennard, Eric J. Belin de Chantemèle · 2020 · Journal of the American Heart Association
51. Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV
    Andréa Sebben Kramer, Alexandre Ramos Lazzarotto, Eduardo Sprinz, Waldomiro Carlos Manfrói · 2009 · Arquivos Brasileiros de Cardiologia
52. GH/GHRH axis in HIV lipodystrophy
    Takara Leah Stanley, Steven Kyle Grinspoon · 2008 · Pituitary
53. Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals
    Signe Westring Worm, Caroline Anne Sabin, Peter Reiss, Wafaa El‐Sadr, Antonella d’Arminio Monforte, Christian Pradier, Rodolphe Thiébaut, Matthew G. Law, Martin Rickenbach, Stéphane De Wit et al. · 2008 · Diabetes Care
54. HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology
    Jonathan A. Hudson, Rashida A. Ferrand, Samuel Nguku Gitau, Marianne Mureithi, Pasquale Maffia, Shirjel R. Alam, Anoop S.V. Shah · 2024 · Circulation Research
55. Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
    S.M.E. Vrouenraets, Ferdinand W.N.M. Wit, Evian Fernandez Garcia, GJ Moyle, Akil Jackson, Clotilde Allavena, François Raffi, DT Jayaweera, Stefan Mauss, Christine Katlama et al. · 2011 · HIV Medicine
56. Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults
    Andrew D Carr, Armin Ritzhaupt, Wei Zhang, Roberto Zajdenverg, Cassy Workman, José M. Gatell, Pedro Enrique Cahn, Ricardo L. Chaves · 2008 · AIDS
57. The Spectrum of Atherosclerotic Coronary Artery Disease in HIV Patients
    Abdul Hakeem, Sabha Bhatti, Mehmet Çilingiroğlu · 2010 · Current Atherosclerosis Reports
58. Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options
    Susanna Naggie, Charles B. Hicks · 2010 · Journal of Antimicrobial Chemotherapy
59. Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study
    Kenneth A. Lichtenstein, Rachel L. D. Hart, Kathleen C. Wood, Samuel A. Bozzette, Kate A. Buchacz, John T. Brooks · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
60. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development
    Janessa M. Smith, Charles W. Flexner · 2017 · AIDS
61. Contemporary protease inhibitors and cardiovascular risk
    Jens Dilling Lundgren, Amanda Mocroft, Lene Ryom · 2017 · Current Opinion in Infectious Diseases
62. The EuroSIDA study: 25 years of scientific achievements
    Kamilla Grønborg Laut, Ole Kirk, Jürgen Kurt Rockstroh, Andrew N. Phillips, Bruno Ledergerber, José M. Gatell, Brian Gazzard, Andrzéj Horban, Igor Karpov, Marcelo H. Losso et al. · 2019 · HIV Medicine
63. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk
    Pádraig McGettrick, Patrick W. G. Mallon, Caroline Anne Sabin · 2020 · Expert Review of Anti-infective Therapy
64. HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health
    Corey Casper, Heidi M. Crane, Manoj P. Menon, Deborah Money · 2017 · World Bank, Washington, DC eBooks
65. Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients
    Morris Schambelan, Peter W.F. Wilson, Kevin E. Yarasheski, W. Todd Cade, Víctor G. Dávila‐Román, Ralph B. D’Agostino, Tarek A. Helmy, Matthew G. Law, Kristin E. Mondy, Sharon Nachman et al. · 2008 · Circulation
66. Effect of a dietary intervention and n–3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV
    Margo N. Woods, CHRISTINE A. WANKE, Pei‐Ra Ling, Kristy M. Hendricks, Alice Tang, Tamsin A. Knox, Charlotte E Andersson, Kimberly R. Dong, Sally C. Skinner, Bruce Ryan Bistrian · 2009 · American Journal of Clinical Nutrition
67. The contribution of HIV infection to intracranial arterial remodeling: A pilot study
    José Gutierrez, Mitchell S.V. Elkind, Carol Kaiser Petito, David Y. Chung, Andrew J. Dwork, Randolph S. Marshall · 2012 · Neuropathology
68. Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy
    Judith A. Aberg · 2009 · Endocrinology and Metabolism Clinics of North America
69. The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice
    Andrea Mencarelli, Sabrina Cipriani, Barbara Renga, Daniela Francisci, Giuseppe Palladino, Eleonora Distrutti, Franco Baldelli, Stefano Fiorucci · 2010 · PLoS ONE
70. Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV‐1‐infected individuals receiving combination antiretroviral therapy
    Ulrik Sloth Kristoffersen, Klaus Fuglsang Kofoed, Gitte Kronborg, Thomas Benfield, Andreas Kjær, Anne‐Mette Lebech · 2009 · HIV Medicine
71. Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study
    Christine Katlama, Lambert Assoumou, M. A. Valantin, Cathia Soulié, Claudine Duvivier, Laetitia Chablais, S. Kolta, Gilles Pialoux, P. Mercié, Anne Simon et al. · 2014 · Journal of Antimicrobial Chemotherapy
72. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients
    Stacy D. Fisher, Brinder Kanda, Tracie L. Miller, Steven E. Lipshultz · 2011 · American Journal of Cardiovascular Drugs
73. Cardiovascular Disease in Adult and Pediatric HIV/AIDS
    Cheryl L. McDonald, Jonathan R. Kaltman · 2009 · Journal of the American College of Cardiology
74. Comorbidity Acquired Before HIV Diagnosis and Mortality in Persons Infected and Uninfected With HIV: A Danish Population-Based Cohort Study
    Nicolai Lohse, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Lars N. Nielsen, Henrik Toft Sørensen, Niels Obel · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
75. Obesity and Dyslipidemia in Behaviorally HIV‐Infected Young Women: Adolescent Trials Network Study 021
    Kathleen M. Mulligan, D. Robert Harris, Dina Monte, Sonia Stoszek, Patricia J Emmanuel, Dana Sue Hardin, Bill G. Kapogiannis, Carol J. Worrell, William A. Meyer, John W. Sleasman et al. · 2009 · Clinical Infectious Diseases
76. Outcomes of patients with human immunodeficiency virus infection undergoing cardiovascular surgery in the United States
    Michael P. Robich, Nicholas K. Schiltz, Douglas R. Johnston, Stephanie Mick, Wayne Tse, Colleen Gorman Koch, Edward G. Soltesz · 2014 · Journal of Thoracic and Cardiovascular Surgery
77. Pregnane X Receptor Mediates Dyslipidemia Induced by the HIV Protease Inhibitor Amprenavir in Mice
    Robert Nathaniel Helsley, Yipeng Sui, Ni Ai, Se‐Hyung Park, William Jeffrey Welsh, Changcheng Zhou · 2013 · Molecular Pharmacology
78. Therapy for HIV
    Barry S. Peters, K. Conway · 2011 · Advances in Dental Research
79. Discrepant coagulation profile in HIV infection
    Anna Karen Haugaard, Tamara T. Lund, Carsten Birch, Frederikke Falkencrone Rönsholt, Marius Trøseid, Henrik Ullum, Jan Gerstoft, Per I. Johansson, Susanne Dam Nielsen, Sisse Rye Ostrowski · 2013 · AIDS
80. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy
    Lander Egaña-Gorroño, E. Martínez, B. Cormand, T. Escribà, J. Gatell, M. Arnedo · 2013 · AIDS (London)
81. AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment
    Kathleen Falster, Jun Yong Choi, Basil J Donovan, Chris J. Duncombe, Brian P. Mulhall, David Sowden, Jialun Zhou, Matthew G. Law · 2009 · AIDS
82. Issues in co-morbid severe mental illnesses in HIV infected individuals
    Andrew F. Angelino, Glenn J. Treisman · 2008 · International Review of Psychiatry
83. Novel functions of PXR in cardiometabolic disease
    Changcheng Zhou · 2016 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
84. Is low‐level HIV ‐1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    Olof Elvstam, Patrik Medstrand, Marianne Jansson, P-E Isberg, Magnus Gisslén, Per Björkman · 2019 · HIV Medicine
85. Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus
    Renee A Pond, Lauren Frances Collins, Cecile Delille Lahiri · 2021 · Open Forum Infectious Diseases
86. HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy
    Paul W. Hruz, Qingyun Yan, Heidi Struthers, Patrick Y. Jay · 2008 · The FASEB Journal
87. Treatment Options for HIV-Associated Central Fat Accumulation
    Joseph Cofrancesco, Eric S. Freedland, Grace A. McComsey · 2008 · AIDS Patient Care and STDs
88. Long-Term Combination Antiretroviral Therapy Is Associated with the Risk of Coronary Plaques in African Americans with HIV Infection
    Shenghan Lai, John A Bartlett, Hong C. Lai, Richard D. Moore, Joseph Cofrancesco, Harpreet K. Pannu, Wenjing Tong, Wei Meng, Hui Sun, Elliot K. Fishman · 2009 · AIDS Patient Care and STDs
89. Effects of aging and smoking on carotid intima–media thickness in HIV-infection
    Kathleen V. Fitch, Sara E. Dolan Looby, Alison M. Rope, Peace Eneh, Linda Hemphill, Hang Lee, Steven Kyle Grinspoon · 2012 · AIDS
90. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
    Ingjerd Wangensteen Manner, Morten Bækken, Olav Oektedalen, Ingrid Os · 2012 · Blood Pressure
91. Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients
    Marc‐Antoine Valantin, Randa Bittar, P. de Truchis, Diane Bollens, Laurence Slama, Philippe Giral, Dominique Bonnefont‐Rousselot, P. Petour, Camille Aubron‐Olivier, Dominique G. Costagliola et al. · 2010 · Journal of Antimicrobial Chemotherapy
92. The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment
    Enrique Bernal, J.J. Serrano, Ángeles Muñoz, Irene Marín, Mar Masiá, Félix Gutiérrez, Alfredo Cano · 2016 · AIDS Research and Human Retroviruses
93. Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapy
    Kristin E. Mondy, Lisa de las Fuentes, Alan D. Waggoner, Nur F. Önen, Coco Bopp, Sherry Lassa‐Claxton, William G. Powderly, Víctor G. Dávila‐Román, Kevin E. Yarasheski · 2008 · AIDS
94. Can the Risk of Cardiovascular Disease in HIV-Infected Patients Be Estimated from Conventional Risk Prediction Tools?
    Nina Friis‐Møller, Signe Westring Worm · 2007 · Clinical Infectious Diseases
95. Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ ritonavir, in pretreated children at 96 weeks
    the HIV–NAT 017 Study Team, Torsak Bunupuradah, Jasper van der Lugt, Pope Kosalaraksa, Chulapan Engchanil, Pitch Boonrak, Thanyawee Puthanakit, Tawan Mengthaisong, Apicha Mahanontharit, Pagakrong Lumbiganon et al. · 2009 · Antiviral Therapy
96. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START ) trial
    Elsayed Z. Soliman, Shweta Sharma, Keikawus Arastéh, David Alain Wohl, Amit C. Achhra, Giuseppe Tambussi, Jemma L. O’Connor, James H. Stein, DA Duprez, JD Neaton et al. · 2015 · HIV Medicine
97. HIV-associated lipodystrophy: a review from a Brazilian perspective
    Eduardo Sprinz, Marcelle Duarte Alves, Carlos Roberto Brites · 2014 · Therapeutics and Clinical Risk Management
98. Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial
    Gerd Fätkenheuer, Claudine Duvivier, A. Rieger, J. Durant, D. Rey, W. Schmidt, Andrew D. Hill, Yvon van Delft, S. Marks, on behalf of the SENSE Study Team et al. · 2011 · Journal of Antimicrobial Chemotherapy
99. Primary vasculitis of the central nervous system in patients infected with HIV‐1 in the HAART era
    Giovanna Melica, Pierre Brugières, Anne‐Sophie Lascaux, Yves Lévy, Jean‐Daniel Lelièvre · 2009 · Journal of Medical Virology
100. Endothelial cells and cathepsins: biochemical and biomechanical regulation
     M. Platt, W. Shockey · 2015 · Biochimie